Product Highlight - Moxifloxacin (Floxsafe/Floxsafe IV)

29 Nov 2024
Product Highlight - Moxifloxacin (Floxsafe/Floxsafe IV)

FLOXSAFE ensures fast recovery because of:

  • Minimal side effects & risk of relapse1
  • Optimized bioavailability1
  • Xcellent safety and tolerability profile3
  • Increased confidence with efficacy2
    - works for both Gram (-) and Gram (+) bacteria2
    - works even for atypical pathogens2

    References:
    1.     Finished Product Certificate of Analysis. MSN Laboratories Pvt Ltd. AR No: FP2203052; SpecNo. RPS-TM01-001-03.
    2.     WHO updated guidelines for drug-resistant tuberculosis (2016).
    3.     Certificate of Analysis. Center of Excellence in Drug Research, Evaluation and Studies Inc. C.A No: 22-M-1117. Date of Issuance 07/03/2023


BIOCARE LIFESCIENCES, INC.
4th Flr 393 Goodwill Bldg, Sen Gil Puyat Ave,
Brgy Bel-Air, Metro Manila
Tel No: (+63-2) 8809 0182
Email: info@biocarelifesciences.com

Related MIMS Drugs